Neuwelt, A J

Cabozantinib use in renal cell carcinoma. [electronic resource] - Drugs of today (Barcelona, Spain : 1998) May 2017 - 299-307 p. digital

Publication Type: Journal Article; Review

1699-3993

10.1358/dot.2017.53.5.2623107 doi


Anilides--adverse effects
Animals
Antineoplastic Agents--adverse effects
Carcinoma, Renal Cell--drug therapy
Drug Interactions
Humans
Kidney Neoplasms--drug therapy
Protein Kinase Inhibitors--adverse effects
Proto-Oncogene Mas
Pyridines--adverse effects
Treatment Outcome